News Current page: 5

Hannes Kempter joined the SHS team in May 2023. Hannes holds a German-French Bachelor’s degree from ESB and CESEM, followed by a Master’s degree in Finance from WHU, including a semester abroad in Florida. He started his career in the M&A team at the investment bank Raymond James. There, his focus from day one was […]

Paris-based SHS portfolio company PathoQuest SAS is a leader in the development and delivery of next-generation sequencing (NGS) tests for biopharmaceuticals. PathoQuest recently published a study with Charles River Laboratories International Inc. showing that PathoQuest’s GMP-compliant, NGS-based test demonstrates greater ability to detect viral contamination compared to in vivo tests. The aim of the study […]

The Baden-Württemberg-based robotics company ESSERT GmbH, which has been part of the SHS portfolio since August 2023 and specialises in the development of intelligent automation solutions for a wide range of application areas with a focus on the pharmaceutical, life science and general industry sectors, has won the prestigious ISPE RAYA Award together with Vetter […]

Pharmaceutical company AMW recently announced that it has achieved a key milestone in opening up new markets within the European Union (EU) and beyond with the final report of the first Notified Body Opinion (NBO) for its goserelin implant. The active ingredient goserelin is a synthetic peptide that can be used primarily in the treatment […]

Since its foundation, the Austrian medical technology manufacturer Tyromotion has continuously brought new products to the market and established a well thought-out overall concept for neurorehabilitation with TYROTHERAPY. This concept has now been expanded to include a product series for medical training therapy (MTT-LINE), which optimally complements the existing product portfolio. In addition, June 2023 […]

The advantages of syndicates: SHS Capital’s healthcare specialisation in the cap table In the ever-evolving private equity landscape, there is an undeniable advantage in specialisation and syndication. At its core, healthcare is not just about investment and returns; it is a sector that requires a deep understanding of complex elements, from the latest technological breakthroughs […]

The German Private Equity Investor SHS Capital has completed the Final Closing of its sixth fund generation The targeted fund volume of EUR 200 million could significantly be overachieved with ca. EUR 270 million and is more than doubling the predecessor fund’s size The new fund will invest in European growing healthcare companies and allocates […]

SHS Capital has acquired a majority stake in the Baden-Württemberg-based robotics company ESSERT GmbH ESSERT develops intelligent automation solutions for a wide range of applications with a focus on the pharmaceutical, life science and general industrial sectors The company’s core product is the ESSERT MicroFactory, a modular production platform for the automation of low-volume, high-mix […]

Our investors, portfolio representatives, SHS senior advisors and healthcare experts were invited to the Hotel Krone in the centre of Tübingen. The day offered exciting presentations on healthcare investments and outlooks on economic developments and medical innovations in the coming years. Furthermore, four of the SHS portfolio companies gave exciting presentations about their companies and […]

Another format that SHS has specifically created for its portfolio companies is the SHS portfolio workshops. These take place quarterly, covering various topics. The aim is to discuss topics that concern a large proportion of the portfolio companies and to provide the companies the opportunity to exchange ideas and knowledge, to discuss approaches to solving […]

The new training and networking format is created for newer employees as well as current and former interns and is intended to provide practical insights into selected topics from the private equity industry. Speakers are both external and experienced SHS colleagues. For the first session, SHS managed to secure Sebastian Schreiber from SySS as external […]

Guillaume Balz joined the SHS team as Investment Manager in January 2023. After obtaining his Bachelor’s degree in Business and Economics in Dortmund and Athens, he completed his Master’s degree in Finance and Strategic Management in Copenhagen. He then decided to join Simon-Kucher, where he advised companies on marketing, sales, pricing and go-to-market. From the […]